Skip to main content
Clinical Trials/CTRI/2019/07/020042
CTRI/2019/07/020042
Completed
Phase 2

Clinical evaluation of the effect on oral administration of tarÄ? mÄ?ttirai in management of VENKUTTAM

Santhoshkumar 0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L80- Vitiligo
Sponsor
Santhoshkumar
Enrollment
40
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 24, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Santhoshkumar

Eligibility Criteria

Inclusion Criteria

  • The patient attending to the OPD will be screened for the following symptoms and will be included in the study
  • Primary symptoms
  • 1\. Hypopigmented patches with hyperpigmented border without any structural changes in any part of the body surface.
  • 2\. Children who are willing to undergo blood tests for laboratory investigations

Exclusion Criteria

  • Tinea versicolor
  • Chemical leucoderma
  • Dermatological manifestation of leprosy
  • Pityriasis alba
  • Total albinism
  • White patches in mucous membrane

Outcomes

Primary Outcomes

Not specified

Similar Trials